Your browser doesn't support javascript.
loading
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy.
Iacoboni, Gloria; Navarro, Víctor; Martín-López, Ana África; Rejeski, Kai; Kwon, Mi; Jalowiec, Katarzyna Aleksandra; Amat, Paula; Reguera-Ortega, Juan Luis; Gallur, Laura; Blumenberg, Viktoria; Gutiérrez-Herrero, Sara; Roddie, Claire; Benzaquén, Ana; Delgado-Serrano, Javier; Sánchez-Salinas, Mario Andrés; Bailén, Rebeca; Carpio, Cecilia; López-Corral, Lucia; Hernani, Rafael; Bastos, Mariana; O'Reilly, Maeve; Martín-Martín, Lourdes; Subklewe, Marion; Barba, Pere.
Afiliación
  • Iacoboni G; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Navarro V; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martín-López AÁ; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Rejeski K; Oncology Data Science (ODySey) Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Kwon M; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Jalowiec KA; Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain.
  • Amat P; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • Reguera-Ortega JL; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.
  • Gallur L; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Blumenberg V; Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Gutiérrez-Herrero S; Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain.
  • Roddie C; Hematology Department, University College London Cancer Institute, London, United Kingdom.
  • Benzaquén A; Department of Hematology and Central Hematology Laboratory, University Hospital of Bern, Bern, Switzerland.
  • Delgado-Serrano J; Haematology Department, Hospital Clínico Universitario, Valencia, Spain.
  • Sánchez-Salinas MA; INCLIVA Research Institute, Valencia, Spain.
  • Bailén R; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC, Universidad de Sevilla, Sevilla, Spain.
  • Carpio C; Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • López-Corral L; Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Hernani R; Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Bastos M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.
  • O'Reilly M; Laboratory for Translational Cancer Immunology, Gene Center of the LMU Munich, Munich, Germany.
  • Martín-Martín L; German Cancer Consortium (DKTK) and Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Subklewe M; Cancer Research Centre (IBMCC, USAL-CSIC), Institute for Biomedical Research of Salamanca (IBSAL) and Department of Medicine and Cytometry Service (NUCLEUS Research Support Platform), University of Salamanca (USAL), Salamanca, Spain.
  • Barba P; Hematology Department, University College London Cancer Institute, London, United Kingdom.
J Clin Oncol ; 42(2): 205-217, 2024 Jan 10.
Article en En | MEDLINE | ID: mdl-37874957

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2024 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Eliminación de Componentes Sanguíneos / Linfoma de Células B Grandes Difuso / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: J Clin Oncol Año: 2024 Tipo del documento: Article País de afiliación: España